LONDON BROKER RATINGS: UBS cuts SSE; Citi lifts Compass
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More
| Price | 80.80p on 28-11-2025 at 19:40:05 |
|---|---|
| Change | 0.30p 0.37% |
| Buy | 80.70p |
| Sell | 80.50p |
| Last Trade: | Unknown 5,896.00 at 80.80p |
| Day's Volume: | 945,163 |
| Last Close: | 80.80p |
| Open: | 80.50p |
| ISIN: | GB00B4YZN328 |
| Day's Range | 80.20p - 81.00p |
| 52wk Range: | 64.80p - 97.90p |
| Market Capitalisation: | £1.55b |
| VWAP: | 80.65206p |
| Shares in Issue: | 1.92b |
Coats Group Plc (COA) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 5,896 | 80.80p | SI Trade Negotiated Trade |
16:46:55 - 28-Nov-25 |
| Buy* | 474,183 | 80.80p | Suspected BUY Trade |
16:35:10 - 28-Nov-25 |
| Sell* | 217 | 80.50p | Automatic Execution |
16:29:53 - 28-Nov-25 |
| Sell* | 100 | 80.50p | Automatic Execution |
16:29:53 - 28-Nov-25 |
| Sell* | 215 | 80.60p | Automatic Execution |
16:29:44 - 28-Nov-25 |
| Buy* | 2 | 80.70p | SI Trade |
16:28:20 - 28-Nov-25 |
| Sell* | 100 | 80.60p | Automatic Execution |
16:26:21 - 28-Nov-25 |
| Sell* | 1,181 | 80.60p | Automatic Execution |
16:26:21 - 28-Nov-25 |
| Sell* | 318 | 80.60p | Automatic Execution |
16:26:21 - 28-Nov-25 |
| Sell* | 500 | 80.60p | SI Trade |
16:26:15 - 28-Nov-25 |
Coats Group Plc (COA) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 7th Nov 2025 7:00 am | RNS | Trading Statement |
| 5th Nov 2025 2:45 pm | RNS | Director Declaration |
| 30th Oct 2025 7:00 am | RNS | Completion of OrthoLite acquisition |
| 20th Oct 2025 12:41 pm | RNS | Director/PDMR Shareholding |
| 17th Oct 2025 1:42 pm | RNS | Holding(s) in Company |
| 6th Oct 2025 1:06 pm | RNS | Block listing Interim Review |
| 16th Sep 2025 2:00 pm | RNS | Director Declaration |
| 12th Sep 2025 3:22 pm | RNS | Holding(s) in Company |
| 11th Sep 2025 3:13 pm | RNS | Holding(s) in Company |
| 10th Sep 2025 1:09 pm | RNS | Director/PDMR Shareholding |